Clinical Trials Logo

Muscle Weakness clinical trials

View clinical trials related to Muscle Weakness.

Filter by:

NCT ID: NCT06020703 Recruiting - COVID-19 Clinical Trials

A Study of Healthy Microbiome, Healthy Mind

Start date: February 26, 2024
Phase: N/A
Study type: Interventional

Researchers are doing this study to find out if a high fermented food diet is tolerable, and if it will help improve quality of life after surviving a critical illness, including severe COVID-19, by promoting gut health recovery and decreasing gut inflammation.

NCT ID: NCT06012201 Not yet recruiting - Clinical trials for Atrophy of Rectus Femoris Muscle (Physical Finding)

Relationship Between Protein Intake and ICU Skeletal Muscle Weakness

Start date: September 1, 2023
Phase:
Study type: Observational [Patient Registry]

Muscle wasting is a common finding in critically ill patients and is associated with adverse outcomes. A good strategy for avoiding or decreasing muscle loss is adding adequate quantities of protein to the nutritional therapy administered during the acute phase of the disease during the ICU stay. The aim of this prospective study is to compare the effect of different levels of protein enteral feeding on Rectus Femoris Muscle mass in mechanically ventilated patients.

NCT ID: NCT06006832 Recruiting - Myasthenia Gravis Clinical Trials

A Prospective Cohort Study of Myasthenia Gravis in China

Start date: August 20, 2023
Phase:
Study type: Observational

The goal of this prospective cohort study is to investigate long-term therapeutic strategies for myasthenia gravis (MG) and identify potential biomarkers. The main questions it aims to answer are: 1. Whether low-dose oral steroids may lead to a reduction in the recurrence rate among patients with MG. 2. To identify potential biomarkers that can predict disease progression and prognosis. This study recruits well-controlled patients with MG. Based on patient preferences and considerations such as coexisting conditions (e.g., uncontrolled hypertension, diabetes, severe osteoporosis, obesity), the participants will be non-randomly divided into two groups: a maintenance steroid therapy group and a withdrawal group (withdraw all immunosuppresants). Subsequently, these groups of patients will undergo long-term follow-up assessments.

NCT ID: NCT06002945 Recruiting - Myasthenia Gravis Clinical Trials

Exploring Outcomes and Characteristics of Myasthenia Gravis 2

EXPLORE-MG2
Start date: January 12, 2021
Phase:
Study type: Observational [Patient Registry]

The goal of this prospective observational study is to create a network repository of clinical data and biological samples to help researchers learn more about myasthenia gravis.

NCT ID: NCT06002334 Active, not recruiting - Bronchiectasis Clinical Trials

Relationship Between Nutritional State and Respiratory Muscle Weakness in Adult Patients With Bronchietasis

Start date: February 23, 2023
Phase:
Study type: Observational

To establish a relationship between malnutrion and respiratory muscle dysfunction in patients with bronchectasis

NCT ID: NCT05992025 Recruiting - Myasthenia Gravis Clinical Trials

Digital Phenotyping and Lifestyle Intervention in Patients With Myasthenia Gravis

DIG-MG
Start date: July 10, 2023
Phase: N/A
Study type: Interventional

Myasthenia Gravis (MG) is a chronic autoimmune neurological disorder where an antibody attack of muscle receptors causes fatigable skeletal muscle weakness. In addition to fatigue, several MG patients experience general fatigue. Small supervised studies during 12 weeks of physical exercise interventions have indicated safety and beneficial neuromuscular outcomes in MG patients. Longer and unsupervised studies are required to obtain guidelines for physical activity in MG patients. Further, the development of smart rings enables remote digital supervision of physical activity, sleep, and biological parameters such as heart frequency, number of steps, and temperature. These parameters could add to the lack of biomarkers in MG. The project design is a randomized controlled trial with a lifestyle intervention to improve fatigue in the autoimmune neuromuscular disease Myasthenia Gravis (MG). The intervention includes digital group counseling regarding physical activity, sleep, general health, and digital follow-up with a "smart ring" (OURA).

NCT ID: NCT05973396 Completed - Muscle Weakness Clinical Trials

The Effects of Mental and Physical Fatigue to Force Production in Adults

Start date: July 18, 2022
Phase: N/A
Study type: Interventional

The primary objective is to investigate the correlation between physical and mental fatigue to lower extremity force production in adults to determine if there is an association of performance output that is inhibited by mental and physical stressors that mimic sport environments that can be further investigated to determine the importance of not only physical training and exercise for athletes, but also mental and cognitive exercises with physical task to enhance performance training and rehabilitation of individuals. In adults, how does physical and mental fatigue in combination compared to those who are just physically fatigued affect average peak height in performance of five CMJ with hands on hips.

NCT ID: NCT05967611 Recruiting - Weakness, Muscle Clinical Trials

Hip Abductor Function During Trendelenburg Test

Start date: July 25, 2023
Phase:
Study type: Observational

This study will use electromyography and dynamometry to evaluate gluteal muscle activation during the Trendelenburg hip abduction test in different hip positions.

NCT ID: NCT05956964 Recruiting - Muscle Weakness Clinical Trials

NM Balance Regulation With ULLS and Loss of Sleep

Start date: August 10, 2023
Phase: N/A
Study type: Interventional

The goal of this trial is to learn about how restricted sleep and not bearing weight on the leg affects muscle strength and posture control. Participants will walk exclusively on one leg, sleep at differing intervals, and complete posture tests, muscle strength tests, and muscle imaging. Researchers will compare adequate sleep and restricted sleep to see if muscle strength and posture are affected.

NCT ID: NCT05941962 Recruiting - Chronic Stroke Clinical Trials

Use of Hand-held Dynamometry to Obtain Objective Measures of Lower Extremity Force Production With Chronic Stroke

Start date: June 5, 2023
Phase:
Study type: Observational

This study wants to know if using handheld dynamometry (HHD) to test leg strength in persons who have had a stroke, will reduce mistakes and give therapists better information to use for therapy. This study will collect normal values of leg muscle peak force production, cumulative peak force production, and sustained peak force production in patients with chronic stroke.